Quantitative Progesterone and Medroxyprogesterone acetate (MPA) Hormone Testing analysis on Macaques specimens
Closed Special Notice Posted
- Solicitation number
- 000HCKBG-2024-84793
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541380 Testing Laboratories and Services
- Place of performance
- Atlanta, Georgia 30329, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC) has issued a Special Notice for a sole source firm fixed price purchase order to conduct quantitative progesterone and medroxyprogesterone acetate (MPA) hormone testing analysis on macaque specimens. The purpose of this contract is to provide the CDC's National Center for HIV, Viral Hepatitis, and STD Prevention (NCHHSTP)/Division of HIV Prevention (DHP)/Laboratory Branch with written data and results from the hormone testing assays.
The CDC intends to award this contract to the University of Wisconsin System. Interested parties may identify their interest and capability to respond to the requirement or submit proposals, but this is not a request for competitive quotations. All quotations or responses received within 15 days of the issuance of this notice will be considered by the government, though the decision to hold a competitive procurement is solely at the government's discretion. Quotations or responses should be emailed to the contract specialist by the close of business on May 2, 2024.
Notice text
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to University of Wisconsin System, 21 N Park St., Ste 6301, Madison, Wisconsin 53715.
CDC’s primary objective is to conduct macaque hormone testing assays to determine progesterone and medroxyprogesterone levels in macaque specimens and provide written report containing the data/results to the Centers for Disease Control (CDC)/National Center for HIV, Viral Hepatitis, and STD Prevention (NCHHSTP)/Division of HIV Prevention (DHP)/ Laboratory Branch. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.
This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist, Alverta Lopez at qvb0@cdc.gov by COB May 2, 2024.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity